An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia

BACKGROUND: Androgenetic alopecia is a condition with a high prevalence worldwide and affects both males and females. Currently, only 2 approved treatments exist: finasteride (males only) and minoxidil 2 or 5% solution (males and females). METHODS: We conducted a randomized, open-label, multicenter...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Skin Pharmacol Physiol
Autores principales: Dhurat, Rachita, Chitallia, Jill, May, Theodor W., Jayaraaman, Ammani M., Madhukara, Jithendriya, Anandan, Subbu, Vaidya, Pradyumna, Klenk, Adolf
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger AG 2018
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5804833/
https://ncbi.nlm.nih.gov/pubmed/29055953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000481141
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares